C
Bristol-Myers Squibb Company BMY
$48.79 $0.511.06% NYSE
Recommendation
Prev Close
$48.28
Volume
13,503,939
Avg Vol (90D)
13,988,451
Market Cap
$98.25B
Dividend & Yield
$2.44(5.05%)
52-Week Range
$39.35 - $63.33
P/E (TTM)
18.14
EPS (TTM)
$2.66
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
4/29/2025 - MarketBeat
Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing
6/2/2025 - Zacks Investment Research
Bristol Myers CEO explains why he's spending billions on BioNTech deal
6/2/2025 - Invezz News
US Manufacturing Shrinks, Again Open Interest 6/2/2025
6/2/2025 - Bloomberg Markets and Finance-YouTube
Bristol-Myers (BMY) Licenses BioNTech's Immunotherapy in $11 billion Deal
6/2/2025 - Insider Monkey
Why BioNTech Stock Soared Today
6/2/2025 - Fool.com Headlines
Bristol-Myers Squibb (BMY) Receives a Hold from Citi
6/2/2025 - TipRanks Financial Blog
Sanofi-Blueprint deal is a bullish signal about biotech M&A
6/2/2025 - Yahoo! Finance-YouTube
Keystone Financial Planning Inc. Has $9.74 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)
6/2/2025 - Ticker Report
Douglas Lane & Associates LLC Sells 48,110 Shares of Bristol-Myers Squibb (NYSE:BMY)
6/2/2025 - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Milestone Asset Management LLC
6/2/2025 - MarketBeat
Czech National Bank Has $28.43 Million Stake in Bristol-Myers Squibb (NYSE:BMY)
6/2/2025 - MarketBeat
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and ...
6/2/2025 - GuruFocus
Bristol-Myers Squibb Co (BMY) Partners with BioNTech for Global Development of BNT327 BMY ...
6/2/2025 - GuruFocus
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
6/2/2025 - Globe Newswire
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
6/2/2025 - Business Wire
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Mid American Wealth Advisory Group Inc.
6/2/2025 - Ticker Report
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)
6/2/2025 - StockStory Articles
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Bristol-Myers Squibb (BMY)
6/2/2025 - TipRanks Financial Blog
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Quantum Financial Advisors LLC
6/1/2025 - Ticker Report
Castle Rock Wealth Management LLC Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
6/1/2025 - Ticker Report
Douglas Lane & Associates LLC Sells 48,110 Shares of Bristol-Myers Squibb (NYSE:BMY)
6/1/2025 - Ticker Report
Meyer Handelman Co. Sells 7,905 Shares of Bristol-Myers Squibb (NYSE:BMY)
6/1/2025 - MarketBeat
Atlas Brown Inc. Sells 321 Shares of Bristol-Myers Squibb (NYSE:BMY)
5/31/2025 - Ticker Report
MarketBeat Week in Review – 02/03 - 02/07
2/8/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$47.64B
EBITDA (TTM)
$19.25B
EBIT (TTM)
$11.13B
Net Income (TTM)
$5.42B
Balance Sheet
Total Assets (Q)
$92.43B
Total Debt (Q)
$51.27B
Total Liabilities (Q)
$74.98B
Book Value Per Share (Q)
$8.55
Cash Flow
Cash from Operations (TTM)
$14.31B
Cash from Investing (TTM)
-$2.23B
Cash from Financing (TTM)
-$10.51B
Net Change in Cash (TTM)
$1.54B
Filings
Filing Date
Thursday, April 24, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Jul 21 and 25 (est)
Price History
Loading...
Beta
0.35
7-Day Total Return
3.81%
30-Day Total Return
-0.89%
60-Day Total Return
-18.05%
90-Day Total Return
-13.61%
Year to Date Total Return
-12.20%
1-Year Total Return
24.57%
2-Year Total Return
-17.15%
3-Year Total Return
-27.05%
5-Year Total Return
-2.83%
52-week Low
Jul 05, 2024 - $39.35
52-week High
Mar 11, 2025 - $63.33
Valuation
Market Cap
$98.25B - Large Cap
Enterprise Value
$137.46B
Price/Sales (TTM)
2.07
Price/Book (Q)
5.65
Dividends and Shares
Shares Outstanding
2.04B
Dividend Per Share (Most Recent)
$0.62
Dividend Per Share (TTM)
$2.44
Corporate Info
Website
www.bms.com
Phone Number
609 252 4621
Address
Route 206 & Province Line Road
Princeton, NJ 08543
Country
United States
Year Founded
1887
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology... more
NYSE 06/02/2025 4:00PM Eastern Quotes delayed